Richard N. Fedorak
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Helicobacter pylori-related gastroenterology studies, Gut microbiota and health, Eosinophilic Esophagitis
Most-Cited Works
- → Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease(2013)2,657 cited
- → An overview of clinical decision support systems: benefits, risks, and strategies for success(2020)2,635 cited
- → Infliximab Maintenance Therapy for Fistulizing Crohn's Disease(2004)2,201 cited
- → Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial(2006)1,710 cited
- → Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial(2007)1,030 cited
- → Methotrexate for the Treatment of Crohn's Disease(1995)917 cited
- → Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial(2011)880 cited
- → Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice(1999)760 cited
- → A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease(2008)743 cited
- → VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis(2005)733 cited